找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers in Liver Disease; Victor R. Preedy Living reference work 20200th edition

[復制鏈接]
樓主: dentin
41#
發(fā)表于 2025-3-28 18:17:32 | 只看該作者
Biomarkers to Monitor Graft Function Following Liver Transplantation,(albumin, bilirubin, prothrombin time). Novel genetic markers such as microRNAs also show potential as more accurate or specific biomarker for various types of injury and functions. Some of these serum biomarkers were shown to be promising in predicting disease or severity of injury when measured in
42#
發(fā)表于 2025-3-28 22:50:30 | 只看該作者
43#
發(fā)表于 2025-3-29 00:35:15 | 只看該作者
Cortisol as Biomarkers in Cirrhosis, Child Pugh and model for end-stage liver disease scores. The diagnosis of adrenal insufficiency in cirrhosis constitutes a crucial point. Published studies have used a variety of biochemical criteria to define abnormalities in adrenal function during liver cirrhosis. Common methods used in the gene
44#
發(fā)表于 2025-3-29 05:36:15 | 只看該作者
,Fibrinogen α-Chain as a Serum Marker of Liver Disease,have been reproduced by different laboratories, and recently a marked downregulation of this protein fragment has also been described in the initial stages of liver fibrosis. In this chapter, we have described the potential role of fibrinogen α chain and particularly the 5.9 kDa fragment of fibrinog
45#
發(fā)表于 2025-3-29 10:36:19 | 只看該作者
46#
發(fā)表于 2025-3-29 13:35:36 | 只看該作者
Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantation,r more effective treatment intervention. It is especially helpful to guide changes in immunosuppression and to monitor immunosuppression minimization. This new approach may contribute to achieve more effective, less toxic personalized immunosuppression.
47#
發(fā)表于 2025-3-29 19:22:21 | 只看該作者
48#
發(fā)表于 2025-3-29 22:32:23 | 只看該作者
49#
發(fā)表于 2025-3-30 00:07:23 | 只看該作者
Hydroxyproline as a Biomarker in Liver Disease, marker for diagnosis or measurement of the anti-fibrotic activity of therapeutic interventions of herbal or non-herbal medicine argues its importance as noninvasive fibrotic detecting biomarker in chronic liver diseases with severe fibrosis.
50#
發(fā)表于 2025-3-30 06:38:26 | 只看該作者
https://doi.org/10.1007/978-3-7091-1519-0ant fibrosis. It showed promising results for predicting the presence of fibrosis in pediatric patients with NAFLD. Transient elastography, a noninvasive and objective but expensive method, showed higher performance in diagnosing significant fibrosis than APRI.
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-10 02:36
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
焦作市| 凤阳县| 湘潭市| 宁晋县| 泉州市| 登封市| 卢湾区| 东乡族自治县| 宁津县| 金昌市| 从化市| 永济市| 京山县| 石棉县| 新疆| 长岭县| 盐亭县| 安多县| 祁连县| 曲麻莱县| 大安市| 梨树县| 松江区| 正定县| 汾阳市| 中卫市| 普安县| 从江县| 胶南市| 上饶县| 蒙阴县| 孟村| 清原| 北海市| 西乌| 南充市| 中牟县| 乃东县| 讷河市| 三江| 敦化市|